The fact that GDF-11 treatment of stromal cells reduces both migration/homing capacity of co-cultured HSPCs and CXCR4 expression in the stroma-associated fraction of HSPCs implies that a disruption of SDF-1 signaling may make an important contribution to the MDS phenotype. The gene discussed is CXCL12; the disease is myelodysplastic syndrome.